C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01)
Patent
CA 2554263
The inventive composition comprises at least one type of antibody selected in a group (i) of anti-Env-SU MSRV/HERV-W antibodies or in a group of anti-TLR4 antibodies specifically linkable with the soluble fraction of a Env protein of MSRV/HERV-W or to a TLR4 receptor of the soluble fraction of the Env protein of MSRV/HERV-W.
Composition comprenant au moins un anticorps choisi dans le groupe (i) des anticorps anti-Env-SU MSRV/HERV-W ou dans le groupe (ii) des anticorps anti-TLR4 capables de se lier spécifiquement à la fraction soluble de la protéine Env de MSRV/HERV-W ou au récepteur TLR4 de la fraction soluble de la protéine Env de MSRV/HERV-W, et un véhicule pharmaceutiquement acceptable.
Jouvin-Marche Evelyne
Marche Patrice
Perron Herve
Rolland Alexandre
Biomerieux
Institut National de La Sante Et de La Recherche Medicale (i.n.s
Norton Rose Canada S.e.n.c.r.l. S.r.l./llp
LandOfFree
Composition for treating pagthology associated with msrv/herv-w does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating pagthology associated with msrv/herv-w, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating pagthology associated with msrv/herv-w will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2069956